American Portfolios Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $378K | Hold |
1,123
| – | – | 0.02% | 757 |
|
|
2022
Q2 | $369K | Sell |
1,123
-14
| -1% | -$4.6K | 0.02% | 792 |
|
|
2022
Q1 | $497K | Sell |
1,137
-3
| -0.3% | -$1.31K | 0.02% | 733 |
|
|
2021
Q4 | $500K | Sell |
1,140
-5
| -0.4% | -$2.19K | 0.02% | 740 |
|
|
2021
Q3 | $637K | Hold |
1,145
| – | – | 0.02% | 612 |
|
|
2021
Q2 | $588K | Buy |
1,145
+280
| +32% | +$144K | 0.02% | 645 |
|
|
2021
Q1 | $676K | Buy |
865
+142
| +20% | +$111K | 0.03% | 546 |
|
|
2020
Q4 | $394K | Sell |
723
-5
| -0.7% | -$2.72K | 0.02% | 636 |
|
|
2020
Q3 | $334K | Buy |
728
+2
| +0.3% | +$917 | 0.02% | 609 |
|
|
2020
Q2 | $447K | Sell |
726
-2
| -0.3% | -$1.23K | 0.03% | 467 |
|
|
2020
Q1 | $346K | Buy |
728
+3
| +0.4% | +$1.43K | 0.03% | 470 |
|
|
2019
Q4 | $420K | Sell |
725
-3
| -0.4% | -$1.74K | 0.03% | 483 |
|
|
2019
Q3 | $479K | Hold |
728
| – | – | 0.04% | 409 |
|
|
2019
Q2 | $563K | Buy |
728
+695
| +2,106% | +$538K | 0.05% | 356 |
|
|
2019
Q1 | $23.5K | Sell |
33
-23
| -41% | -$16.4K | ﹤0.01% | 1533 |
|
|
2018
Q4 | $26K | Buy |
56
+34
| +155% | +$15.8K | ﹤0.01% | 1276 |
|
|
2018
Q3 | $18.6K | Sell |
22
-163
| -88% | -$138K | ﹤0.01% | 1507 |
|
|
2018
Q2 | $128K | Buy |
185
+8
| +5% | +$5.53K | 0.02% | 718 |
|
|
2018
Q1 | $78.9K | Buy |
177
+167
| +1,670% | +$74.5K | 0.01% | 840 |
|
|
2017
Q4 | $4.59K | Buy |
+10
| New | +$4.59K | ﹤0.01% | 1872 |
|